nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—UGT2B7—Epirubicin—thyroid cancer	0.146	0.274	CbGbCtD
Valproic Acid—UGT1A9—Sorafenib—thyroid cancer	0.136	0.253	CbGbCtD
Valproic Acid—CYP2B6—Sorafenib—thyroid cancer	0.0429	0.0801	CbGbCtD
Valproic Acid—CYP3A5—Sorafenib—thyroid cancer	0.0338	0.0631	CbGbCtD
Valproic Acid—CYP2C8—Sorafenib—thyroid cancer	0.0325	0.0607	CbGbCtD
Valproic Acid—CYP2C19—Sorafenib—thyroid cancer	0.0272	0.0509	CbGbCtD
Valproic Acid—CYP2B6—Doxorubicin—thyroid cancer	0.026	0.0486	CbGbCtD
Valproic Acid—CYP1A2—Sorafenib—thyroid cancer	0.0251	0.047	CbGbCtD
Valproic Acid—CYP2C9—Sorafenib—thyroid cancer	0.0227	0.0423	CbGbCtD
Valproic Acid—CYP3A4—Vandetanib—thyroid cancer	0.0219	0.0408	CbGbCtD
Valproic Acid—CYP3A4—Sorafenib—thyroid cancer	0.0132	0.0246	CbGbCtD
Valproic Acid—HDAC2—parathyroid gland—thyroid cancer	0.00939	0.129	CbGeAlD
Valproic Acid—CYP3A4—Doxorubicin—thyroid cancer	0.00799	0.0149	CbGbCtD
Valproic Acid—ACADSB—saliva-secreting gland—thyroid cancer	0.00391	0.0538	CbGeAlD
Valproic Acid—OGDH—trachea—thyroid cancer	0.0038	0.0522	CbGeAlD
Valproic Acid—HDAC9—trachea—thyroid cancer	0.00335	0.046	CbGeAlD
Valproic Acid—HDAC2—Afatinib—Vandetanib—thyroid cancer	0.00321	0.534	CbGdCrCtD
Valproic Acid—ACADSB—trachea—thyroid cancer	0.00302	0.0415	CbGeAlD
Valproic Acid—OGDH—thyroid gland—thyroid cancer	0.003	0.0413	CbGeAlD
Valproic Acid—UGT1A8—head—thyroid cancer	0.00287	0.0394	CbGeAlD
Valproic Acid—HDAC2—neck—thyroid cancer	0.00285	0.0391	CbGeAlD
Valproic Acid—HDAC2—Gefitinib—Vandetanib—thyroid cancer	0.00281	0.466	CbGdCrCtD
Valproic Acid—OGDH—head—thyroid cancer	0.00267	0.0366	CbGeAlD
Valproic Acid—HDAC9—thyroid gland—thyroid cancer	0.00265	0.0364	CbGeAlD
Valproic Acid—ACADSB—thyroid gland—thyroid cancer	0.00239	0.0328	CbGeAlD
Valproic Acid—HDAC9—head—thyroid cancer	0.00235	0.0323	CbGeAlD
Valproic Acid—HDAC2—saliva-secreting gland—thyroid cancer	0.00222	0.0305	CbGeAlD
Valproic Acid—ALDH5A1—thyroid gland—thyroid cancer	0.0021	0.0289	CbGeAlD
Valproic Acid—OGDH—lymph node—thyroid cancer	0.00187	0.0257	CbGeAlD
Valproic Acid—ALDH5A1—head—thyroid cancer	0.00186	0.0256	CbGeAlD
Valproic Acid—ABAT—thyroid gland—thyroid cancer	0.0018	0.0247	CbGeAlD
Valproic Acid—HDAC9—lymph node—thyroid cancer	0.00165	0.0226	CbGeAlD
Valproic Acid—ABAT—head—thyroid cancer	0.0016	0.0219	CbGeAlD
Valproic Acid—ACADSB—lymph node—thyroid cancer	0.00148	0.0204	CbGeAlD
Valproic Acid—HDAC2—thyroid gland—thyroid cancer	0.00135	0.0186	CbGeAlD
Valproic Acid—ALDH5A1—lymph node—thyroid cancer	0.00131	0.0179	CbGeAlD
Valproic Acid—SLC16A1—thyroid gland—thyroid cancer	0.0012	0.0165	CbGeAlD
Valproic Acid—HDAC2—head—thyroid cancer	0.0012	0.0165	CbGeAlD
Valproic Acid—SLC22A5—saliva-secreting gland—thyroid cancer	0.00113	0.0155	CbGeAlD
Valproic Acid—ABAT—lymph node—thyroid cancer	0.00112	0.0154	CbGeAlD
Valproic Acid—SLC16A1—head—thyroid cancer	0.00107	0.0147	CbGeAlD
Valproic Acid—SLC22A5—trachea—thyroid cancer	0.000869	0.0119	CbGeAlD
Valproic Acid—HDAC2—lymph node—thyroid cancer	0.000841	0.0116	CbGeAlD
Valproic Acid—SLC22A8—head—thyroid cancer	0.000807	0.0111	CbGeAlD
Valproic Acid—SLC16A1—lymph node—thyroid cancer	0.000748	0.0103	CbGeAlD
Valproic Acid—SLC22A5—thyroid gland—thyroid cancer	0.000688	0.00945	CbGeAlD
Valproic Acid—PTGS1—trachea—thyroid cancer	0.000682	0.00938	CbGeAlD
Valproic Acid—CYP1A2—thyroid gland—thyroid cancer	0.000623	0.00856	CbGeAlD
Valproic Acid—PTGS1—thyroid gland—thyroid cancer	0.00054	0.00742	CbGeAlD
Valproic Acid—CYP2B6—head—thyroid cancer	0.00053	0.00728	CbGeAlD
Valproic Acid—PTGS1—head—thyroid cancer	0.000479	0.00658	CbGeAlD
Valproic Acid—SLC22A5—lymph node—thyroid cancer	0.000427	0.00587	CbGeAlD
Valproic Acid—PTGS1—lymph node—thyroid cancer	0.000335	0.00461	CbGeAlD
Valproic Acid—Increased appetite—Doxorubicin—thyroid cancer	0.000285	0.00108	CcSEcCtD
Valproic Acid—Affect lability—Epirubicin—thyroid cancer	0.000285	0.00107	CcSEcCtD
Valproic Acid—Hypersensitivity—Sorafenib—thyroid cancer	0.000283	0.00107	CcSEcCtD
Valproic Acid—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00028	0.00106	CcSEcCtD
Valproic Acid—Face oedema—Epirubicin—thyroid cancer	0.000279	0.00105	CcSEcCtD
Valproic Acid—Asthenia—Sorafenib—thyroid cancer	0.000276	0.00104	CcSEcCtD
Valproic Acid—Mood swings—Epirubicin—thyroid cancer	0.000274	0.00103	CcSEcCtD
Valproic Acid—Lethargy—Doxorubicin—thyroid cancer	0.000273	0.00103	CcSEcCtD
Valproic Acid—Pruritus—Sorafenib—thyroid cancer	0.000272	0.00103	CcSEcCtD
Valproic Acid—Ataxia—Epirubicin—thyroid cancer	0.000272	0.00103	CcSEcCtD
Valproic Acid—Hyponatraemia—Doxorubicin—thyroid cancer	0.000269	0.00101	CcSEcCtD
Valproic Acid—Diplopia—Doxorubicin—thyroid cancer	0.000268	0.00101	CcSEcCtD
Valproic Acid—Osteoarthritis—Doxorubicin—thyroid cancer	0.000268	0.00101	CcSEcCtD
Valproic Acid—Dry skin—Epirubicin—thyroid cancer	0.000265	0.001	CcSEcCtD
Valproic Acid—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000264	0.000997	CcSEcCtD
Valproic Acid—Abdominal pain upper—Epirubicin—thyroid cancer	0.000264	0.000997	CcSEcCtD
Valproic Acid—Affect lability—Doxorubicin—thyroid cancer	0.000263	0.000994	CcSEcCtD
Valproic Acid—Diarrhoea—Sorafenib—thyroid cancer	0.000263	0.000994	CcSEcCtD
Valproic Acid—Breast disorder—Epirubicin—thyroid cancer	0.000261	0.000987	CcSEcCtD
Valproic Acid—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00026	0.000983	CcSEcCtD
Valproic Acid—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00026	0.000983	CcSEcCtD
Valproic Acid—Face oedema—Doxorubicin—thyroid cancer	0.000258	0.000975	CcSEcCtD
Valproic Acid—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000255	0.000963	CcSEcCtD
Valproic Acid—Muscular weakness—Epirubicin—thyroid cancer	0.000255	0.000963	CcSEcCtD
Valproic Acid—Dizziness—Sorafenib—thyroid cancer	0.000254	0.00096	CcSEcCtD
Valproic Acid—Mood swings—Doxorubicin—thyroid cancer	0.000253	0.000957	CcSEcCtD
Valproic Acid—Ataxia—Doxorubicin—thyroid cancer	0.000252	0.00095	CcSEcCtD
Valproic Acid—Dysphagia—Epirubicin—thyroid cancer	0.00025	0.000944	CcSEcCtD
Valproic Acid—Influenza—Epirubicin—thyroid cancer	0.00025	0.000944	CcSEcCtD
Valproic Acid—Eosinophilia—Epirubicin—thyroid cancer	0.000247	0.000934	CcSEcCtD
Valproic Acid—Dry skin—Doxorubicin—thyroid cancer	0.000245	0.000926	CcSEcCtD
Valproic Acid—Pancreatitis—Epirubicin—thyroid cancer	0.000245	0.000925	CcSEcCtD
Valproic Acid—Vomiting—Sorafenib—thyroid cancer	0.000244	0.000923	CcSEcCtD
Valproic Acid—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000244	0.000923	CcSEcCtD
Valproic Acid—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000244	0.000923	CcSEcCtD
Valproic Acid—Rash—Sorafenib—thyroid cancer	0.000242	0.000916	CcSEcCtD
Valproic Acid—Dermatitis—Sorafenib—thyroid cancer	0.000242	0.000915	CcSEcCtD
Valproic Acid—Breast disorder—Doxorubicin—thyroid cancer	0.000242	0.000913	CcSEcCtD
Valproic Acid—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000241	0.00091	CcSEcCtD
Valproic Acid—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000241	0.00091	CcSEcCtD
Valproic Acid—Headache—Sorafenib—thyroid cancer	0.000241	0.00091	CcSEcCtD
Valproic Acid—Bronchitis—Epirubicin—thyroid cancer	0.00024	0.000908	CcSEcCtD
Valproic Acid—Pancytopenia—Epirubicin—thyroid cancer	0.000237	0.000896	CcSEcCtD
Valproic Acid—Muscular weakness—Doxorubicin—thyroid cancer	0.000236	0.000891	CcSEcCtD
Valproic Acid—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000236	0.000891	CcSEcCtD
Valproic Acid—Dysuria—Epirubicin—thyroid cancer	0.000234	0.000882	CcSEcCtD
Valproic Acid—Neutropenia—Epirubicin—thyroid cancer	0.000234	0.000882	CcSEcCtD
Valproic Acid—Dysphagia—Doxorubicin—thyroid cancer	0.000231	0.000873	CcSEcCtD
Valproic Acid—Influenza—Doxorubicin—thyroid cancer	0.000231	0.000873	CcSEcCtD
Valproic Acid—Pollakiuria—Epirubicin—thyroid cancer	0.000231	0.000872	CcSEcCtD
Valproic Acid—Eosinophilia—Doxorubicin—thyroid cancer	0.000229	0.000865	CcSEcCtD
Valproic Acid—Nausea—Sorafenib—thyroid cancer	0.000228	0.000863	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000228	0.000861	CcSEcCtD
Valproic Acid—Weight increased—Epirubicin—thyroid cancer	0.000227	0.000859	CcSEcCtD
Valproic Acid—Pancreatitis—Doxorubicin—thyroid cancer	0.000227	0.000856	CcSEcCtD
Valproic Acid—Weight decreased—Epirubicin—thyroid cancer	0.000226	0.000854	CcSEcCtD
Valproic Acid—Pneumonia—Epirubicin—thyroid cancer	0.000224	0.000846	CcSEcCtD
Valproic Acid—Drowsiness—Epirubicin—thyroid cancer	0.000223	0.000841	CcSEcCtD
Valproic Acid—Bronchitis—Doxorubicin—thyroid cancer	0.000222	0.00084	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000221	0.000834	CcSEcCtD
Valproic Acid—Pancytopenia—Doxorubicin—thyroid cancer	0.00022	0.000829	CcSEcCtD
Valproic Acid—Stomatitis—Epirubicin—thyroid cancer	0.000217	0.00082	CcSEcCtD
Valproic Acid—Conjunctivitis—Epirubicin—thyroid cancer	0.000217	0.000818	CcSEcCtD
Valproic Acid—Urinary tract infection—Epirubicin—thyroid cancer	0.000217	0.000818	CcSEcCtD
Valproic Acid—Neutropenia—Doxorubicin—thyroid cancer	0.000216	0.000817	CcSEcCtD
Valproic Acid—Dysuria—Doxorubicin—thyroid cancer	0.000216	0.000817	CcSEcCtD
Valproic Acid—Sweating—Epirubicin—thyroid cancer	0.000214	0.000807	CcSEcCtD
Valproic Acid—Pollakiuria—Doxorubicin—thyroid cancer	0.000214	0.000807	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000211	0.000797	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000211	0.000796	CcSEcCtD
Valproic Acid—Weight increased—Doxorubicin—thyroid cancer	0.00021	0.000795	CcSEcCtD
Valproic Acid—Epistaxis—Epirubicin—thyroid cancer	0.00021	0.000794	CcSEcCtD
Valproic Acid—Weight decreased—Doxorubicin—thyroid cancer	0.000209	0.00079	CcSEcCtD
Valproic Acid—Sinusitis—Epirubicin—thyroid cancer	0.000209	0.000789	CcSEcCtD
Valproic Acid—Agranulocytosis—Epirubicin—thyroid cancer	0.000208	0.000785	CcSEcCtD
Valproic Acid—Pneumonia—Doxorubicin—thyroid cancer	0.000207	0.000783	CcSEcCtD
Valproic Acid—Drowsiness—Doxorubicin—thyroid cancer	0.000206	0.000779	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000204	0.000772	CcSEcCtD
Valproic Acid—Bradycardia—Epirubicin—thyroid cancer	0.000204	0.000769	CcSEcCtD
Valproic Acid—Haemoglobin—Epirubicin—thyroid cancer	0.000201	0.000759	CcSEcCtD
Valproic Acid—Stomatitis—Doxorubicin—thyroid cancer	0.000201	0.000759	CcSEcCtD
Valproic Acid—Rhinitis—Epirubicin—thyroid cancer	0.000201	0.000757	CcSEcCtD
Valproic Acid—Urinary tract infection—Doxorubicin—thyroid cancer	0.0002	0.000757	CcSEcCtD
Valproic Acid—Conjunctivitis—Doxorubicin—thyroid cancer	0.0002	0.000757	CcSEcCtD
Valproic Acid—Haemorrhage—Epirubicin—thyroid cancer	0.0002	0.000755	CcSEcCtD
Valproic Acid—Hypoaesthesia—Epirubicin—thyroid cancer	0.000199	0.000752	CcSEcCtD
Valproic Acid—Pharyngitis—Epirubicin—thyroid cancer	0.000199	0.00075	CcSEcCtD
Valproic Acid—Sweating—Doxorubicin—thyroid cancer	0.000198	0.000746	CcSEcCtD
Valproic Acid—Urinary tract disorder—Epirubicin—thyroid cancer	0.000198	0.000746	CcSEcCtD
Valproic Acid—Oedema peripheral—Epirubicin—thyroid cancer	0.000197	0.000744	CcSEcCtD
Valproic Acid—Connective tissue disorder—Epirubicin—thyroid cancer	0.000197	0.000742	CcSEcCtD
Valproic Acid—Urethral disorder—Epirubicin—thyroid cancer	0.000196	0.00074	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000195	0.000736	CcSEcCtD
Valproic Acid—Epistaxis—Doxorubicin—thyroid cancer	0.000194	0.000734	CcSEcCtD
Valproic Acid—Sinusitis—Doxorubicin—thyroid cancer	0.000193	0.00073	CcSEcCtD
Valproic Acid—Visual impairment—Epirubicin—thyroid cancer	0.000193	0.000728	CcSEcCtD
Valproic Acid—Agranulocytosis—Doxorubicin—thyroid cancer	0.000192	0.000727	CcSEcCtD
Valproic Acid—Erythema multiforme—Epirubicin—thyroid cancer	0.000189	0.000714	CcSEcCtD
Valproic Acid—Bradycardia—Doxorubicin—thyroid cancer	0.000188	0.000712	CcSEcCtD
Valproic Acid—Eye disorder—Epirubicin—thyroid cancer	0.000187	0.000706	CcSEcCtD
Valproic Acid—Tinnitus—Epirubicin—thyroid cancer	0.000186	0.000704	CcSEcCtD
Valproic Acid—Haemoglobin—Doxorubicin—thyroid cancer	0.000186	0.000703	CcSEcCtD
Valproic Acid—Rhinitis—Doxorubicin—thyroid cancer	0.000186	0.000701	CcSEcCtD
Valproic Acid—Haemorrhage—Doxorubicin—thyroid cancer	0.000185	0.000699	CcSEcCtD
Valproic Acid—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000184	0.000695	CcSEcCtD
Valproic Acid—Pharyngitis—Doxorubicin—thyroid cancer	0.000184	0.000694	CcSEcCtD
Valproic Acid—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000183	0.00069	CcSEcCtD
Valproic Acid—Oedema peripheral—Doxorubicin—thyroid cancer	0.000182	0.000689	CcSEcCtD
Valproic Acid—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000182	0.000687	CcSEcCtD
Valproic Acid—Angiopathy—Epirubicin—thyroid cancer	0.000181	0.000685	CcSEcCtD
Valproic Acid—Urethral disorder—Doxorubicin—thyroid cancer	0.000181	0.000685	CcSEcCtD
Valproic Acid—Immune system disorder—Epirubicin—thyroid cancer	0.000181	0.000682	CcSEcCtD
Valproic Acid—Mediastinal disorder—Epirubicin—thyroid cancer	0.00018	0.000681	CcSEcCtD
Valproic Acid—Chills—Epirubicin—thyroid cancer	0.000179	0.000678	CcSEcCtD
Valproic Acid—Arrhythmia—Epirubicin—thyroid cancer	0.000179	0.000675	CcSEcCtD
Valproic Acid—Visual impairment—Doxorubicin—thyroid cancer	0.000178	0.000674	CcSEcCtD
Valproic Acid—Alopecia—Epirubicin—thyroid cancer	0.000177	0.000668	CcSEcCtD
Valproic Acid—Mental disorder—Epirubicin—thyroid cancer	0.000175	0.000662	CcSEcCtD
Valproic Acid—Erythema multiforme—Doxorubicin—thyroid cancer	0.000175	0.000661	CcSEcCtD
Valproic Acid—Malnutrition—Epirubicin—thyroid cancer	0.000174	0.000658	CcSEcCtD
Valproic Acid—Eye disorder—Doxorubicin—thyroid cancer	0.000173	0.000653	CcSEcCtD
Valproic Acid—Tinnitus—Doxorubicin—thyroid cancer	0.000173	0.000652	CcSEcCtD
Valproic Acid—Flatulence—Epirubicin—thyroid cancer	0.000172	0.000648	CcSEcCtD
Valproic Acid—Tension—Epirubicin—thyroid cancer	0.000171	0.000645	CcSEcCtD
Valproic Acid—Dysgeusia—Epirubicin—thyroid cancer	0.00017	0.000644	CcSEcCtD
Valproic Acid—Nervousness—Epirubicin—thyroid cancer	0.000169	0.000639	CcSEcCtD
Valproic Acid—Back pain—Epirubicin—thyroid cancer	0.000168	0.000636	CcSEcCtD
Valproic Acid—Angiopathy—Doxorubicin—thyroid cancer	0.000168	0.000634	CcSEcCtD
Valproic Acid—Muscle spasms—Epirubicin—thyroid cancer	0.000167	0.000632	CcSEcCtD
Valproic Acid—Immune system disorder—Doxorubicin—thyroid cancer	0.000167	0.000631	CcSEcCtD
Valproic Acid—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000167	0.00063	CcSEcCtD
Valproic Acid—Chills—Doxorubicin—thyroid cancer	0.000166	0.000627	CcSEcCtD
Valproic Acid—Arrhythmia—Doxorubicin—thyroid cancer	0.000165	0.000624	CcSEcCtD
Valproic Acid—Vision blurred—Epirubicin—thyroid cancer	0.000164	0.00062	CcSEcCtD
Valproic Acid—Alopecia—Doxorubicin—thyroid cancer	0.000164	0.000618	CcSEcCtD
Valproic Acid—Mental disorder—Doxorubicin—thyroid cancer	0.000162	0.000612	CcSEcCtD
Valproic Acid—Ill-defined disorder—Epirubicin—thyroid cancer	0.000162	0.00061	CcSEcCtD
Valproic Acid—Malnutrition—Doxorubicin—thyroid cancer	0.000161	0.000608	CcSEcCtD
Valproic Acid—Anaemia—Epirubicin—thyroid cancer	0.000161	0.000608	CcSEcCtD
Valproic Acid—Agitation—Epirubicin—thyroid cancer	0.00016	0.000604	CcSEcCtD
Valproic Acid—Flatulence—Doxorubicin—thyroid cancer	0.000159	0.0006	CcSEcCtD
Valproic Acid—Tension—Doxorubicin—thyroid cancer	0.000158	0.000597	CcSEcCtD
Valproic Acid—Dysgeusia—Doxorubicin—thyroid cancer	0.000158	0.000596	CcSEcCtD
Valproic Acid—Malaise—Epirubicin—thyroid cancer	0.000157	0.000593	CcSEcCtD
Valproic Acid—Nervousness—Doxorubicin—thyroid cancer	0.000156	0.000591	CcSEcCtD
Valproic Acid—Vertigo—Epirubicin—thyroid cancer	0.000156	0.000591	CcSEcCtD
Valproic Acid—Leukopenia—Epirubicin—thyroid cancer	0.000156	0.000589	CcSEcCtD
Valproic Acid—Back pain—Doxorubicin—thyroid cancer	0.000156	0.000589	CcSEcCtD
Valproic Acid—Muscle spasms—Doxorubicin—thyroid cancer	0.000155	0.000585	CcSEcCtD
Valproic Acid—Palpitations—Epirubicin—thyroid cancer	0.000154	0.000581	CcSEcCtD
Valproic Acid—Cough—Epirubicin—thyroid cancer	0.000152	0.000574	CcSEcCtD
Valproic Acid—Vision blurred—Doxorubicin—thyroid cancer	0.000152	0.000573	CcSEcCtD
Valproic Acid—Hypertension—Epirubicin—thyroid cancer	0.00015	0.000568	CcSEcCtD
Valproic Acid—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000149	0.000565	CcSEcCtD
Valproic Acid—Anaemia—Doxorubicin—thyroid cancer	0.000149	0.000562	CcSEcCtD
Valproic Acid—Chest pain—Epirubicin—thyroid cancer	0.000148	0.00056	CcSEcCtD
Valproic Acid—Myalgia—Epirubicin—thyroid cancer	0.000148	0.00056	CcSEcCtD
Valproic Acid—Arthralgia—Epirubicin—thyroid cancer	0.000148	0.00056	CcSEcCtD
Valproic Acid—Agitation—Doxorubicin—thyroid cancer	0.000148	0.000559	CcSEcCtD
Valproic Acid—Anxiety—Epirubicin—thyroid cancer	0.000148	0.000558	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000147	0.000556	CcSEcCtD
Valproic Acid—Discomfort—Epirubicin—thyroid cancer	0.000146	0.000553	CcSEcCtD
Valproic Acid—Malaise—Doxorubicin—thyroid cancer	0.000145	0.000549	CcSEcCtD
Valproic Acid—Dry mouth—Epirubicin—thyroid cancer	0.000145	0.000548	CcSEcCtD
Valproic Acid—Vertigo—Doxorubicin—thyroid cancer	0.000145	0.000547	CcSEcCtD
Valproic Acid—Leukopenia—Doxorubicin—thyroid cancer	0.000144	0.000545	CcSEcCtD
Valproic Acid—Confusional state—Epirubicin—thyroid cancer	0.000143	0.000541	CcSEcCtD
Valproic Acid—Palpitations—Doxorubicin—thyroid cancer	0.000142	0.000538	CcSEcCtD
Valproic Acid—Anaphylactic shock—Epirubicin—thyroid cancer	0.000142	0.000537	CcSEcCtD
Valproic Acid—Oedema—Epirubicin—thyroid cancer	0.000142	0.000537	CcSEcCtD
Valproic Acid—Infection—Epirubicin—thyroid cancer	0.000141	0.000533	CcSEcCtD
Valproic Acid—Cough—Doxorubicin—thyroid cancer	0.000141	0.000531	CcSEcCtD
Valproic Acid—Nervous system disorder—Epirubicin—thyroid cancer	0.000139	0.000526	CcSEcCtD
Valproic Acid—Thrombocytopenia—Epirubicin—thyroid cancer	0.000139	0.000525	CcSEcCtD
Valproic Acid—Hypertension—Doxorubicin—thyroid cancer	0.000139	0.000525	CcSEcCtD
Valproic Acid—Tachycardia—Epirubicin—thyroid cancer	0.000139	0.000524	CcSEcCtD
Valproic Acid—Skin disorder—Epirubicin—thyroid cancer	0.000138	0.000521	CcSEcCtD
Valproic Acid—Hyperhidrosis—Epirubicin—thyroid cancer	0.000137	0.000519	CcSEcCtD
Valproic Acid—Arthralgia—Doxorubicin—thyroid cancer	0.000137	0.000518	CcSEcCtD
Valproic Acid—Myalgia—Doxorubicin—thyroid cancer	0.000137	0.000518	CcSEcCtD
Valproic Acid—Chest pain—Doxorubicin—thyroid cancer	0.000137	0.000518	CcSEcCtD
Valproic Acid—Anxiety—Doxorubicin—thyroid cancer	0.000137	0.000516	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000136	0.000514	CcSEcCtD
Valproic Acid—Discomfort—Doxorubicin—thyroid cancer	0.000136	0.000512	CcSEcCtD
Valproic Acid—Anorexia—Epirubicin—thyroid cancer	0.000135	0.000512	CcSEcCtD
Valproic Acid—Dry mouth—Doxorubicin—thyroid cancer	0.000134	0.000507	CcSEcCtD
Valproic Acid—Hypotension—Epirubicin—thyroid cancer	0.000133	0.000501	CcSEcCtD
Valproic Acid—Confusional state—Doxorubicin—thyroid cancer	0.000133	0.000501	CcSEcCtD
Valproic Acid—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000131	0.000497	CcSEcCtD
Valproic Acid—Oedema—Doxorubicin—thyroid cancer	0.000131	0.000497	CcSEcCtD
Valproic Acid—Infection—Doxorubicin—thyroid cancer	0.000131	0.000493	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000129	0.000489	CcSEcCtD
Valproic Acid—Nervous system disorder—Doxorubicin—thyroid cancer	0.000129	0.000487	CcSEcCtD
Valproic Acid—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000129	0.000486	CcSEcCtD
Valproic Acid—Insomnia—Epirubicin—thyroid cancer	0.000129	0.000485	CcSEcCtD
Valproic Acid—Tachycardia—Doxorubicin—thyroid cancer	0.000128	0.000485	CcSEcCtD
Valproic Acid—Skin disorder—Doxorubicin—thyroid cancer	0.000128	0.000482	CcSEcCtD
Valproic Acid—Paraesthesia—Epirubicin—thyroid cancer	0.000128	0.000482	CcSEcCtD
Valproic Acid—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000127	0.00048	CcSEcCtD
Valproic Acid—Dyspnoea—Epirubicin—thyroid cancer	0.000127	0.000478	CcSEcCtD
Valproic Acid—Somnolence—Epirubicin—thyroid cancer	0.000126	0.000477	CcSEcCtD
Valproic Acid—Anorexia—Doxorubicin—thyroid cancer	0.000125	0.000473	CcSEcCtD
Valproic Acid—Dyspepsia—Epirubicin—thyroid cancer	0.000125	0.000472	CcSEcCtD
Valproic Acid—Decreased appetite—Epirubicin—thyroid cancer	0.000124	0.000467	CcSEcCtD
Valproic Acid—Hypotension—Doxorubicin—thyroid cancer	0.000123	0.000464	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000123	0.000463	CcSEcCtD
Valproic Acid—Fatigue—Epirubicin—thyroid cancer	0.000123	0.000463	CcSEcCtD
Valproic Acid—Pain—Epirubicin—thyroid cancer	0.000122	0.000459	CcSEcCtD
Valproic Acid—Constipation—Epirubicin—thyroid cancer	0.000122	0.000459	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00012	0.000452	CcSEcCtD
Valproic Acid—Insomnia—Doxorubicin—thyroid cancer	0.000119	0.000449	CcSEcCtD
Valproic Acid—Paraesthesia—Doxorubicin—thyroid cancer	0.000118	0.000446	CcSEcCtD
Valproic Acid—Dyspnoea—Doxorubicin—thyroid cancer	0.000117	0.000443	CcSEcCtD
Valproic Acid—Feeling abnormal—Epirubicin—thyroid cancer	0.000117	0.000442	CcSEcCtD
Valproic Acid—Somnolence—Doxorubicin—thyroid cancer	0.000117	0.000441	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000116	0.000439	CcSEcCtD
Valproic Acid—Dyspepsia—Doxorubicin—thyroid cancer	0.000116	0.000437	CcSEcCtD
Valproic Acid—Decreased appetite—Doxorubicin—thyroid cancer	0.000114	0.000432	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000114	0.000429	CcSEcCtD
Valproic Acid—Fatigue—Doxorubicin—thyroid cancer	0.000113	0.000428	CcSEcCtD
Valproic Acid—Urticaria—Epirubicin—thyroid cancer	0.000113	0.000426	CcSEcCtD
Valproic Acid—Pain—Doxorubicin—thyroid cancer	0.000112	0.000425	CcSEcCtD
Valproic Acid—Constipation—Doxorubicin—thyroid cancer	0.000112	0.000425	CcSEcCtD
Valproic Acid—Abdominal pain—Epirubicin—thyroid cancer	0.000112	0.000424	CcSEcCtD
Valproic Acid—Body temperature increased—Epirubicin—thyroid cancer	0.000112	0.000424	CcSEcCtD
Valproic Acid—Feeling abnormal—Doxorubicin—thyroid cancer	0.000108	0.000409	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000108	0.000406	CcSEcCtD
Valproic Acid—Hypersensitivity—Epirubicin—thyroid cancer	0.000105	0.000395	CcSEcCtD
Valproic Acid—Urticaria—Doxorubicin—thyroid cancer	0.000104	0.000394	CcSEcCtD
Valproic Acid—Abdominal pain—Doxorubicin—thyroid cancer	0.000104	0.000393	CcSEcCtD
Valproic Acid—Body temperature increased—Doxorubicin—thyroid cancer	0.000104	0.000393	CcSEcCtD
Valproic Acid—Asthenia—Epirubicin—thyroid cancer	0.000102	0.000385	CcSEcCtD
Valproic Acid—Pruritus—Epirubicin—thyroid cancer	0.000101	0.00038	CcSEcCtD
Valproic Acid—Diarrhoea—Epirubicin—thyroid cancer	9.72e-05	0.000367	CcSEcCtD
Valproic Acid—Hypersensitivity—Doxorubicin—thyroid cancer	9.69e-05	0.000366	CcSEcCtD
Valproic Acid—Asthenia—Doxorubicin—thyroid cancer	9.43e-05	0.000356	CcSEcCtD
Valproic Acid—Dizziness—Epirubicin—thyroid cancer	9.4e-05	0.000355	CcSEcCtD
Valproic Acid—Pruritus—Doxorubicin—thyroid cancer	9.3e-05	0.000351	CcSEcCtD
Valproic Acid—Vomiting—Epirubicin—thyroid cancer	9.03e-05	0.000341	CcSEcCtD
Valproic Acid—Diarrhoea—Doxorubicin—thyroid cancer	9e-05	0.00034	CcSEcCtD
Valproic Acid—Rash—Epirubicin—thyroid cancer	8.96e-05	0.000338	CcSEcCtD
Valproic Acid—Dermatitis—Epirubicin—thyroid cancer	8.95e-05	0.000338	CcSEcCtD
Valproic Acid—Headache—Epirubicin—thyroid cancer	8.9e-05	0.000336	CcSEcCtD
Valproic Acid—Dizziness—Doxorubicin—thyroid cancer	8.69e-05	0.000328	CcSEcCtD
Valproic Acid—Nausea—Epirubicin—thyroid cancer	8.44e-05	0.000319	CcSEcCtD
Valproic Acid—Vomiting—Doxorubicin—thyroid cancer	8.36e-05	0.000316	CcSEcCtD
Valproic Acid—Rash—Doxorubicin—thyroid cancer	8.29e-05	0.000313	CcSEcCtD
Valproic Acid—Dermatitis—Doxorubicin—thyroid cancer	8.28e-05	0.000313	CcSEcCtD
Valproic Acid—Headache—Doxorubicin—thyroid cancer	8.24e-05	0.000311	CcSEcCtD
Valproic Acid—Nausea—Doxorubicin—thyroid cancer	7.81e-05	0.000295	CcSEcCtD
Valproic Acid—CYP2C8—Metabolism—MINPP1—thyroid cancer	6.06e-05	0.0005	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—HPGD—thyroid cancer	6.05e-05	0.000499	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—RXRA—thyroid cancer	6.04e-05	0.000498	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.02e-05	0.000496	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—NDUFA13—thyroid cancer	5.95e-05	0.000491	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—PTEN—thyroid cancer	5.81e-05	0.000479	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—TP53—thyroid cancer	5.81e-05	0.000478	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.76e-05	0.000475	CbGpPWpGaD
Valproic Acid—CYP1A2—Biological oxidations—RXRA—thyroid cancer	5.74e-05	0.000473	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CHST14—thyroid cancer	5.73e-05	0.000472	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—NRAS—thyroid cancer	5.72e-05	0.000472	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—HPGD—thyroid cancer	5.72e-05	0.000471	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TERT—thyroid cancer	5.7e-05	0.000469	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CHST14—thyroid cancer	5.6e-05	0.000461	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—SLC5A5—thyroid cancer	5.55e-05	0.000458	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	5.48e-05	0.000452	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HIF1A—thyroid cancer	5.45e-05	0.000449	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—MINPP1—thyroid cancer	5.41e-05	0.000446	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CALCA—thyroid cancer	5.41e-05	0.000446	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—TPR—thyroid cancer	5.39e-05	0.000444	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PRKAR1A—thyroid cancer	5.3e-05	0.000437	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—TPR—thyroid cancer	5.24e-05	0.000432	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—PPARG—thyroid cancer	5.23e-05	0.000431	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—PTGS2—thyroid cancer	5.2e-05	0.000429	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PRKAR1A—thyroid cancer	5.16e-05	0.000425	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—NDUFA13—thyroid cancer	5.16e-05	0.000425	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TSHR—thyroid cancer	5.06e-05	0.000417	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PRKAR1A—thyroid cancer	4.98e-05	0.00041	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—SLC5A5—thyroid cancer	4.95e-05	0.000408	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—MINPP1—thyroid cancer	4.93e-05	0.000407	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—KRAS—thyroid cancer	4.93e-05	0.000406	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.91e-05	0.000404	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CDK1—thyroid cancer	4.89e-05	0.000403	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—RXRA—thyroid cancer	4.89e-05	0.000403	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CHST14—thyroid cancer	4.85e-05	0.000399	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MEN1—thyroid cancer	4.76e-05	0.000392	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—RXRA—thyroid cancer	4.67e-05	0.000385	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	4.66e-05	0.000384	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—SLC5A5—thyroid cancer	4.62e-05	0.000381	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—HPGD—thyroid cancer	4.61e-05	0.00038	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—NDUFA13—thyroid cancer	4.6e-05	0.000379	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PPARG—thyroid cancer	4.57e-05	0.000377	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—PTEN—thyroid cancer	4.54e-05	0.000374	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—BRAF—thyroid cancer	4.51e-05	0.000372	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—HPGD—thyroid cancer	4.51e-05	0.000372	CbGpPWpGaD
Valproic Acid—CYP3A4—Biological oxidations—RXRA—thyroid cancer	4.43e-05	0.000365	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CHST14—thyroid cancer	4.33e-05	0.000357	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTCH1—thyroid cancer	4.3e-05	0.000354	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—TPR—thyroid cancer	4.26e-05	0.000351	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—MINPP1—thyroid cancer	4.22e-05	0.000348	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—NDUFA13—thyroid cancer	4.2e-05	0.000346	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PRKAR1A—thyroid cancer	4.19e-05	0.000346	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—HRAS—thyroid cancer	4.19e-05	0.000345	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—RXRA—thyroid cancer	4.16e-05	0.000343	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—PTGS2—thyroid cancer	4.12e-05	0.000339	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—NRAS—thyroid cancer	4.05e-05	0.000334	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—SLC5A5—thyroid cancer	4.04e-05	0.000333	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—NRAS—thyroid cancer	3.96e-05	0.000327	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CHST14—thyroid cancer	3.94e-05	0.000325	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—AKT1—thyroid cancer	3.94e-05	0.000325	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SST—thyroid cancer	3.93e-05	0.000324	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—NRG1—thyroid cancer	3.93e-05	0.000324	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—SLC5A5—thyroid cancer	3.93e-05	0.000324	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—HPGD—thyroid cancer	3.91e-05	0.000322	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—RXRA—thyroid cancer	3.88e-05	0.00032	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PPARG—thyroid cancer	3.82e-05	0.000315	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.8e-05	0.000313	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CALCA—thyroid cancer	3.79e-05	0.000312	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—AKT1—thyroid cancer	3.7e-05	0.000305	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—NRAS—thyroid cancer	3.63e-05	0.000299	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PTGS2—thyroid cancer	3.6e-05	0.000296	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—PTEN—thyroid cancer	3.59e-05	0.000296	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NDUFA13—thyroid cancer	3.59e-05	0.000296	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—TERT—thyroid cancer	3.53e-05	0.000291	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—HPGD—thyroid cancer	3.49e-05	0.000287	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—KRAS—thyroid cancer	3.48e-05	0.000287	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—TPR—thyroid cancer	3.47e-05	0.000286	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CDK1—thyroid cancer	3.43e-05	0.000282	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PRKAR1A—thyroid cancer	3.42e-05	0.000282	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—KRAS—thyroid cancer	3.41e-05	0.000281	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—RXRA—thyroid cancer	3.39e-05	0.000279	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HIF1A—thyroid cancer	3.37e-05	0.000278	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CHST14—thyroid cancer	3.37e-05	0.000278	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—AKT1—thyroid cancer	3.35e-05	0.000276	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—RXRA—thyroid cancer	3.3e-05	0.000272	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCND1—thyroid cancer	3.29e-05	0.000271	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—TPR—thyroid cancer	3.28e-05	0.000271	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—MINPP1—thyroid cancer	3.25e-05	0.000268	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	3.23e-05	0.000266	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—SLC5A5—thyroid cancer	3.19e-05	0.000263	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—HPGD—thyroid cancer	3.18e-05	0.000262	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PTEN—thyroid cancer	3.18e-05	0.000262	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.17e-05	0.000261	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PTEN—thyroid cancer	3.14e-05	0.000259	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—KRAS—thyroid cancer	3.12e-05	0.000257	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.1e-05	0.000255	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—PPARG—thyroid cancer	3.09e-05	0.000255	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TP53—thyroid cancer	3.03e-05	0.00025	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PTGS2—thyroid cancer	3e-05	0.000247	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.99e-05	0.000246	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—HRAS—thyroid cancer	2.96e-05	0.000244	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PPARG—thyroid cancer	2.95e-05	0.000243	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—HRAS—thyroid cancer	2.9e-05	0.000239	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—NRAS—thyroid cancer	2.83e-05	0.000234	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.83e-05	0.000233	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—BRAF—thyroid cancer	2.79e-05	0.00023	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TP53—thyroid cancer	2.77e-05	0.000229	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.77e-05	0.000228	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NRG1—thyroid cancer	2.75e-05	0.000227	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—HPGD—thyroid cancer	2.72e-05	0.000224	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—RXRA—thyroid cancer	2.68e-05	0.000221	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—HRAS—thyroid cancer	2.65e-05	0.000219	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—TPR—thyroid cancer	2.65e-05	0.000218	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PPARG—thyroid cancer	2.63e-05	0.000216	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PTEN—thyroid cancer	2.62e-05	0.000216	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—AKT1—thyroid cancer	2.62e-05	0.000216	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	2.61e-05	0.000215	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.61e-05	0.000215	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CHST14—thyroid cancer	2.6e-05	0.000214	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—SLC5A5—thyroid cancer	2.6e-05	0.000214	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—TPR—thyroid cancer	2.59e-05	0.000214	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.58e-05	0.000213	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—AKT1—thyroid cancer	2.56e-05	0.000211	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	2.55e-05	0.00021	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TERT—thyroid cancer	2.47e-05	0.000204	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—SLC5A5—thyroid cancer	2.46e-05	0.000203	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PPARG—thyroid cancer	2.45e-05	0.000202	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—KRAS—thyroid cancer	2.44e-05	0.000201	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.44e-05	0.000201	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HIF1A—thyroid cancer	2.36e-05	0.000195	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—AKT1—thyroid cancer	2.34e-05	0.000193	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PTGS2—thyroid cancer	2.32e-05	0.000191	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PTGS2—thyroid cancer	2.26e-05	0.000186	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—TPR—thyroid cancer	2.24e-05	0.000185	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	2.21e-05	0.000182	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.2e-05	0.000182	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—RXRA—thyroid cancer	2.18e-05	0.00018	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TP53—thyroid cancer	2.17e-05	0.000179	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PPARG—thyroid cancer	2.14e-05	0.000176	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.13e-05	0.000175	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—HPGD—thyroid cancer	2.1e-05	0.000173	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PPARG—thyroid cancer	2.08e-05	0.000172	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HRAS—thyroid cancer	2.07e-05	0.000171	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—AKT1—thyroid cancer	2.07e-05	0.00017	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—RXRA—thyroid cancer	2.07e-05	0.00017	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTGS2—thyroid cancer	2.07e-05	0.00017	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PTEN—thyroid cancer	2.02e-05	0.000167	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—TPR—thyroid cancer	2e-05	0.000165	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2e-05	0.000165	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—SLC5A5—thyroid cancer	1.98e-05	0.000164	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.97e-05	0.000162	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PTEN—thyroid cancer	1.97e-05	0.000162	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—BRAF—thyroid cancer	1.96e-05	0.000161	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1.94e-05	0.00016	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTGS2—thyroid cancer	1.93e-05	0.000159	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—AKT1—thyroid cancer	1.83e-05	0.000151	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—TPR—thyroid cancer	1.83e-05	0.000151	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—AKT1—thyroid cancer	1.81e-05	0.000149	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTEN—thyroid cancer	1.8e-05	0.000148	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.8e-05	0.000148	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.79e-05	0.000147	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—NRAS—thyroid cancer	1.76e-05	0.000145	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PPARG—thyroid cancer	1.69e-05	0.000139	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTGS2—thyroid cancer	1.68e-05	0.000139	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTEN—thyroid cancer	1.68e-05	0.000138	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.68e-05	0.000138	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—RXRA—thyroid cancer	1.67e-05	0.000137	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTGS2—thyroid cancer	1.64e-05	0.000135	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—RXRA—thyroid cancer	1.63e-05	0.000134	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.63e-05	0.000134	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.57e-05	0.00013	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—TPR—thyroid cancer	1.56e-05	0.000129	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.54e-05	0.000127	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—KRAS—thyroid cancer	1.51e-05	0.000125	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—AKT1—thyroid cancer	1.51e-05	0.000124	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.5e-05	0.000124	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTEN—thyroid cancer	1.47e-05	0.000121	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTEN—thyroid cancer	1.43e-05	0.000118	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCND1—thyroid cancer	1.43e-05	0.000118	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—RXRA—thyroid cancer	1.41e-05	0.000116	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.4e-05	0.000116	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.39e-05	0.000115	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PPARG—thyroid cancer	1.38e-05	0.000114	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTEN—thyroid cancer	1.38e-05	0.000114	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.37e-05	0.000113	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.37e-05	0.000113	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTGS2—thyroid cancer	1.33e-05	0.00011	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PPARG—thyroid cancer	1.3e-05	0.000108	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HRAS—thyroid cancer	1.28e-05	0.000106	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.28e-05	0.000106	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—RXRA—thyroid cancer	1.26e-05	0.000104	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NRAS—thyroid cancer	1.23e-05	0.000101	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.23e-05	0.000101	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—AKT1—thyroid cancer	1.22e-05	0.000101	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—TPR—thyroid cancer	1.2e-05	9.93e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.18e-05	9.77e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.17e-05	9.63e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—AKT1—thyroid cancer	1.16e-05	9.6e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTEN—thyroid cancer	1.16e-05	9.57e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—RXRA—thyroid cancer	1.15e-05	9.47e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—AKT1—thyroid cancer	1.13e-05	9.35e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.12e-05	9.21e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.09e-05	9.02e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTGS2—thyroid cancer	1.09e-05	8.94e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KRAS—thyroid cancer	1.06e-05	8.72e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PPARG—thyroid cancer	1.05e-05	8.68e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—AKT1—thyroid cancer	1.04e-05	8.56e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PPARG—thyroid cancer	1.03e-05	8.48e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTGS2—thyroid cancer	1.03e-05	8.46e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—RXRA—thyroid cancer	9.82e-06	8.09e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—AKT1—thyroid cancer	9.68e-06	7.98e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.55e-06	7.87e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTEN—thyroid cancer	9.46e-06	7.8e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—thyroid cancer	9.4e-06	7.75e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC5A5—thyroid cancer	9.02e-06	7.43e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HRAS—thyroid cancer	8.99e-06	7.41e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTEN—thyroid cancer	8.95e-06	7.38e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PPARG—thyroid cancer	8.91e-06	7.34e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—AKT1—thyroid cancer	8.46e-06	6.98e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTGS2—thyroid cancer	8.28e-06	6.82e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—AKT1—thyroid cancer	8.23e-06	6.79e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTGS2—thyroid cancer	8.09e-06	6.67e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PPARG—thyroid cancer	7.95e-06	6.56e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AKT1—thyroid cancer	7.94e-06	6.54e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—RXRA—thyroid cancer	7.58e-06	6.24e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PPARG—thyroid cancer	7.25e-06	5.98e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTEN—thyroid cancer	7.22e-06	5.95e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTEN—thyroid cancer	7.06e-06	5.82e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTGS2—thyroid cancer	7.01e-06	5.78e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—AKT1—thyroid cancer	6.69e-06	5.51e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTGS2—thyroid cancer	6.26e-06	5.16e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PPARG—thyroid cancer	6.2e-06	5.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTEN—thyroid cancer	6.11e-06	5.04e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTGS2—thyroid cancer	5.71e-06	4.7e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTEN—thyroid cancer	5.46e-06	4.5e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—AKT1—thyroid cancer	5.45e-06	4.5e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—AKT1—thyroid cancer	5.16e-06	4.25e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTEN—thyroid cancer	4.98e-06	4.1e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTGS2—thyroid cancer	4.88e-06	4.02e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PPARG—thyroid cancer	4.78e-06	3.94e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTEN—thyroid cancer	4.25e-06	3.5e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AKT1—thyroid cancer	4.16e-06	3.43e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AKT1—thyroid cancer	4.07e-06	3.35e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTGS2—thyroid cancer	3.76e-06	3.1e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKT1—thyroid cancer	3.52e-06	2.9e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTEN—thyroid cancer	3.28e-06	2.7e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKT1—thyroid cancer	3.14e-06	2.59e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKT1—thyroid cancer	2.87e-06	2.36e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKT1—thyroid cancer	2.45e-06	2.02e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKT1—thyroid cancer	1.89e-06	1.56e-05	CbGpPWpGaD
